IAA
CRDF icon

Independent Advisor Alliance’s Cardiff Oncology CRDF Stock Holding History

Independent Advisor Alliance’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-241
Closed -$6K – 362
2018
Q1 		$6K Hold
241
– – ﹤0.01% 345
2017
Q4 		$6K Hold
241
– – ﹤0.01% 325
2017
Q3 		$15K Buy
+241
New +$15K ﹤0.01% 265

Other funds holding CRDF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Independent Advisor Alliance's CRDF Position: Q2 2018 in Review

Independent Advisor Alliance sold out of Cardiff Oncology (CRDF) in Q2 2018, closing a stake of 241 shares — an estimated $6K sold.

Independent Advisor Alliance first reported a position in CRDF in Q3 2017 and held it in 3 quarters. The position peaked at $15K in Q3 2017. 29 funds tracked by Wall St. Rank hold CRDF as of Q2 2018.

  • Independent Advisor Alliance reported no remaining Cardiff Oncology position as of Q2 2018 after selling out during the quarter.
  • Independent Advisor Alliance sold 241 Cardiff Oncology shares in Q2 2018, an estimated $6K.
  • Independent Advisor Alliance first reported a position in Cardiff Oncology in Q3 2017 and held it in 3 quarters.
  • Independent Advisor Alliance's Cardiff Oncology position peaked at $15K in Q3 2017.
  • 29 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2018.

Based on Independent Advisor Alliance's 13F filing for Q2 2018, filed 8 Aug 2018.